Since 1990, Stragen has always been committed to the development of Selected and Advanced Generics. As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we constantly aim at improving the existing therapeutics by offering:
- Niche molecules
- Hard-to-make drugs
- Innovative delivery forms to improve health daily practices
We specialize in the development and production management of complex low-concentration hormonal…
We develop and manage the manufacturing of high-quality parenteral drugs, such as antibiotics…
We offer expertise in the development and production of specialized gels and creams within…
Consumer Health products
Today’s consumers are more digitally connected and educated about the need for healthier lifestyles than ever before. Concerned about preserving their health, they are taking an active role in selecting their treatment options and proactively looking for scientifically supported solutions. Our Health Care Innovation range offers unique, natural formulas made from scientifically selected active ingredients that are clinically proven to answer unmet consumer needs.
Original drugs development
In its continuous commitment to advancing public health, Stragen invests in the development up to proof of concept of patented new drugs addressing orphan diseases or unmet medical needs.
Stragen is honored to partner with biotechnology start-ups, renowned health institutes and innovative stakeholders such as the Institute Pasteur, the Cystic Fibrosis Foundation and BPI France who recognized the unique innovative approach and therapeutic potential of its drug candidates and support their development.